University of California-San Francisco · PharmacologyThe Genomic Access Lab
Kathryn A Phillips · San Francisco, California
Research Focus
Dr. Kathryn A. Phillips' lab focuses on understanding how emerging genomic tests, like cell-free DNA tests and polygenic risk scores, can be integrated into healthcare policies and practices. The lab investigates payer coverage decisions to determine the economic value of these tests in both disease management and screening scenarios. They aim to ensure that advancements in genomic medicine are accessible and beneficial for all patients, addressing issues like equity and disparity in healthcare access.
genomic medicinecell-free DNApolygenic risk scoreshealth policydisease managementscreening testspayer coverageeconomic valuepatient accesshealth disparities
Research Aims
3AIM 01Examine coverage decisions for cfDNA and PRS tests through systematic reviews and stakeholder interviews.
AIM 02Assess the economic value of cfDNA and PRS tests with a patient-centered approach.
AIM 03Identify evidence needs for payer coverage and economic value across various clinical scenarios.
Skills the Lab Values
systematic reviewshealth policy analysisinterviewing stakeholderseconomic modelingevidence synthesispatient-centered researchdata analysisstatistical methodscollaborative researchhealth services research
Output against the department
Publications205top 43% of dept.199th of 462
this lab
most publishedleast published
Citations7.3ktop 50% of dept.229th of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.